Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:
Ensuring that women have easy access to the breast imaging and breast cancer screening services they need to maintain their health is critical across the country. And, currently, levels of access, as well as breast imaging legislation, varies by state. This week, Diagnostic Imaging spoke with Dr. Amy Patel, Medical Director of Liberty Hospital Women's Imaging, about her efforts to enact laws that support women in their screening efforts and why this venture is so important.
For additional video breast imaging coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
COVID-19 has shown no discrimination in its ability to infect and severely impact patients. Men and women from all races and ethnicies, as well as all ages are clearly susceptible to the virus. The differing effects, however, have been felt in how imaging has resumed for various groups, particularly with cancer screenings. In the next edition of The Reading Room podcast, Diagnostic Imaging spoke with Dr. Shalom Kalnicki, chair of radiation oncology at Montefiore and Albert Einstein College of Medicine, about the challenges racial and ethnic minorities face in accessing cancer screening services, as well as the impact COVID-19 has had on this existing problem.
To listen to previous episodes of The Reading Room, click here.
Work continues into helping radiologists identify findings in the brain that are so small they can routinely be overlooked. This week, we will share the results of a study that outlines how radiologists can improve their ability to detect these problems. Look for this coverage as the week progresses.
To read Diagnostic Imaging’s neuroimaging coverage, click here.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.